Dujjawan Boonyanuch, Chinthammitr Yingyong, Ruchutrakool Theera, Hantaweepant Chattree
Division of Haematology Department of Medicine, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand.
EJHaem. 2025 Aug 27;6(4):e70128. doi: 10.1002/jha2.70128. eCollection 2025 Aug.
We aimed to ascertain the prevalence of ααα and ααα triplications in central Thailand and to characterise the phenotypes of individuals harbouring these variants.
We performed a retrospective review of adult (≥ 18 years) samples submitted for polymerase chain reaction-based α-globin mutation analysis at Siriraj Hospital, Mahidol University, Bangkok (January 2012-December 2021). Haematological indices were compared between carriers and non-carriers of α-globin triplications, and clinical severity was assessed in those with co-inherited β-globin mutations.
Among 1559 subjects, α-globin triplication prevalence was 1.28%, with ααα (0.83%) more frequent than ααα (0.45%). Double heterozygosity for an α triplication and a β-globin mutation occurred in 0.9%. Individuals carrying ααα or ααα had lower mean haemoglobin levels (10.00 and 11.23 ± 1.85 g/dL, respectively) than those without triplication (12.35 ± 2.59 g/dL). Among heterozygous β-thalassaemia individuals, co-inheritance of ααα or ααα was associated with significantly reduced mean haemoglobin (8.38 ± 1.58 and 8.28 ± 1.15 g/dL, respectively). This contrasts with the non-triplication group (11.14 ± 1.86 g/dL). Of 14 subjects with double heterozygosity, 8 had thalassaemia intermedia and 6 had thalassaemia trait.
Although uncommon in central Thailand, α-globin triplications can exacerbate anaemia in individuals with co-inherited heterozygous β-globin mutations, supporting routine screening in symptomatic cases. : The authors have confirmed clinical trial registration is not needed for this submission.
我们旨在确定泰国中部地区ααα和ααα三联体的患病率,并对携带这些变异的个体的表型进行特征描述。
我们对2012年1月至2021年12月期间提交至曼谷玛希隆大学诗里拉吉医院进行基于聚合酶链反应的α-珠蛋白突变分析的成人(≥18岁)样本进行了回顾性研究。比较了α-珠蛋白三联体携带者和非携带者的血液学指标,并对共遗传β-珠蛋白突变者的临床严重程度进行了评估。
在1559名受试者中,α-珠蛋白三联体的患病率为1.28%,其中ααα(0.83%)比ααα(0.45%)更常见。α三联体与β-珠蛋白突变的双重杂合子发生率为0.9%。携带ααα或ααα的个体的平均血红蛋白水平(分别为10.00和11.23±1.85 g/dL)低于无三联体者(12.35±2.59 g/dL)。在杂合子β地中海贫血个体中,ααα或ααα的共遗传与平均血红蛋白显著降低相关(分别为8.38±1.58和8.28±1.15 g/dL)。这与非三联体组(11.14±1.86 g/dL)形成对比。在14名双重杂合子受试者中,8例患有中间型地中海贫血,6例具有地中海贫血特征。
尽管α-珠蛋白三联体在泰国中部地区并不常见,但它可加重共遗传杂合子β-珠蛋白突变个体的贫血,支持对有症状病例进行常规筛查。作者已确认本研究无需临床试验注册。